SEC Form 4 · accession 0001225208-16-027641
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B. Ullem
Officer — CVP, CFO
Period of report
Feb 22, 2016
Accepted (ET)
Feb 23, 2016 · 5:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2016 | F | 11,745 | $86.21 | D | 85,411 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 11, 2015, the common stock of Edwards Lifesciences Corporation split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.